| Key Financial Ratios of Alivus Life Sciences (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
39.63 |
38.43 |
38.11 |
35.63 |
32.61 |
|
| Diluted EPS (Rs.) |
39.53 |
38.38 |
38.11 |
35.63 |
32.61 |
|
| Cash EPS (Rs.) |
44.58 |
42.79 |
41.55 |
37.27 |
392.83 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
229.92 |
190.35 |
174.51 |
167.66 |
768.11 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
229.92 |
190.35 |
174.51 |
167.66 |
768.11 |
|
| Dividend / Share(Rs.) |
5.00 |
22.50 |
21.00 |
21.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
194.79 |
186.35 |
176.39 |
173.29 |
1,923.64 |
|
| PBDIT/Share (Rs.) |
58.53 |
56.01 |
54.78 |
51.48 |
603.96 |
|
| PBIT/Share (Rs.) |
53.58 |
51.65 |
51.35 |
48.39 |
569.89 |
|
| PBT/Share (Rs.) |
53.38 |
51.52 |
51.30 |
46.11 |
480.56 |
|
| Net Profit/Share (Rs.) |
39.63 |
38.43 |
38.11 |
34.17 |
358.76 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
30.04 |
30.05 |
31.05 |
29.70 |
31.39 |
|
| PBIT Margin (%) |
27.50 |
27.71 |
29.11 |
27.92 |
29.62 |
|
| PBT Margin (%) |
27.40 |
27.64 |
29.08 |
26.60 |
24.98 |
|
| Net Profit Margin (%) |
20.34 |
20.62 |
21.60 |
19.72 |
18.64 |
|
| Return on Networth / Equity (%) |
17.23 |
20.18 |
21.83 |
20.38 |
46.70 |
|
| Return on Capital Employed (%) |
22.32 |
26.24 |
28.62 |
28.40 |
72.00 |
|
| Return on Assets (%) |
14.23 |
16.51 |
17.28 |
16.94 |
17.60 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.76 |
0.82 |
0.84 |
0.95 |
1.01 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
4.97 |
4.37 |
3.67 |
4.60 |
1.15 |
|
| Quick Ratio (X) |
3.53 |
2.85 |
2.47 |
3.25 |
0.73 |
|
| Inventory Turnover Ratio (X) |
3.56 |
3.59 |
1.96 |
1.95 |
2.11 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
58.54 |
82.65 |
30.72 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
52.57 |
75.81 |
28.17 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
41.46 |
17.35 |
69.28 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
47.43 |
24.19 |
71.83 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
13,157.64 |
9,197.77 |
4,488.68 |
5,111.73 |
0.00 |
|
| EV/Net Operating Revenue (X) |
5.51 |
4.03 |
2.08 |
2.41 |
0.00 |
|
| EV/EBITDA (X) |
18.35 |
13.40 |
6.69 |
8.10 |
0.00 |
|
| MarketCap/Net Operating Revenue (X) |
5.54 |
4.16 |
2.22 |
2.65 |
0.00 |
|
| Retention Ratios (%) |
0.00 |
41.45 |
17.34 |
69.27 |
0.00 |
|
| Price/BV (X) |
4.70 |
4.07 |
2.24 |
2.74 |
0.00 |
|
| Price/Net Operating Revenue |
5.54 |
4.16 |
2.22 |
2.65 |
0.00 |
|
| Earnings Yield |
0.04 |
0.05 |
0.10 |
0.07 |
0.00 |
|
Source : Dion Global Solutions Limited
